Corporate report

Register of interests

Updated 2 February 2026

© Crown copyright 2026

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/members-register-of-interests/register-of-interests

1. Professor Judith Aldridge

Professor of Criminology, University of Manchester

Declaration of interests

  • Advisor, the Staying Safe educational programme of alcohol and drug learning materials for UK university students (2022)
  • George Soros Visiting Chair, School of Public Policy, Central European University (2017)
  • Collaborator, Centre International de Criminologie Comparée (CICC), University of Montreal
  • Member of the International Society for the Study of Drug Policy, European Society of Criminology
  • Editorial Board, Addiction, Research and Theory; Drugs: Education, Prevention and Policy
  • Advisory Board, Recovering Justice UK
  • Advisory work, European Commission, Pompidou Group of the Council of Europe, EMCDDA
  • Consultancy services provided to Release UK
  • Research funding received from:
    • UK Research Councils
    • Nuffield
    • Ministry of Justice (the Netherlands)
    • NESTA
    • Manchester City Council
    • Home Office
    • National Institute for Health Research

2. Professor Steve Allsop

Emeritus Professor, National Drug Research Institute Curtin University Australia

Declaration of interests

  • Chair Alcohol and other Drug Advisory Board WA (West Australian Government)
  • Technical Advisor Australian Government Delegation to the UN Commission on Narcotic Drugs
  • Member, Board Relationships Australia (Western Australia)
  • Member National Suicide Prevention Office Advisory Board (Australia)
  • Member National FASD Advisory Committee (Australia)
  • Member Mental Health and Wellbeing Advisory Group, Australian Defence Force
  • Ambassador, NOFASD (Australia)
  • Member, Country Football Community Advisory Panel (Western Australia)
  • Senior Editor, Addiction
  • Australian Business Consultancy – Dr Steven J Allsop
  • Research Funding:
    • Healthway, Western Australia
    • National Health and Medical Research Council Australia
    • Medical Research Future Fund, Australia
  • Other income:
    • University of Adelaide
    • Country Football Western Australia
    • Various government, sporting and private enterprises in Australia relating to wellbeing and alcohol and other drug related harm in the workplace/sporting institute.
    • Injury Prevention Western Australia.

3. Professor Anne Campbell MBE

Professor in substance use at Queen’s University Belfast School of Social Sciences, Education and Social Work

Declaration of interests

  • National Institute of Drug Abuse (US) Lifetime International Clinical Research Fellow
  • Member of the Treatment and Support Advisory Committee, Northern Ireland Department of Health
  • Co-Director of the Drug and Alcohol Network (DARN), Queens University Belfast
  • Board Member of Ascert (Community Drug and Alcohol service provider in Northern Ireland)
  • Extern, (Community Drug and Alcohol service provider in Northern Ireland) Volunteer shift worker on the Street Injectors Support Service

4. Dr Caroline Copeland

Senior Lecturer in Pharmacology & Toxicology, King’s College London

Declaration of interests         

  • Director, National Programme on Substance Use Mortality (NPSUM)
  • Research funding received from:
    • UK research councils
    • Home Office
    • Local Authorities in England, Wales and Northern Ireland
  • Consultancy services provided to local authorities and police forces in England, Wales and Northern Ireland
  • Fellow, British Pharmacological Society
  • Member of the Society for the Study of Addiction, the UK & Ireland Association of Forensic Toxicologists, the LTG
  • Novel psychoactive substances (NPS) Expert, European Union Drugs Agency (EUDA)

5.  Professor Colin Davidson

Professor of Neuropharmacology, University of Lancashire

Declaration of interests

  • Consultant and Expert Witness for Defence Science & Technology Laboratory, MOD
  • External Examiner for BSc Pharmacology, University of Dundee
  • Editorial Board for the European Journal of Pharmacology; Editorial Board for Pro-gress in Neuropsychopharmacology & Biological Psychiatry
  • Assessment Regulatory Committee for the Royal Pharmaceutical Society
  • Historic Monuments Council member, Northern Ireland Department for Communities
  • Previous funding from:
    • the National Institute on Drug Abuse (NIDA), NIH, USA
    • NC3Rs
    • European Community
    • Health Education England (HEE)

6. Karen Ersche

Professor of Addiction Neuroscience, University of Cambridge

Adjunct Professor of translational addiction research, University of Heidelberg

Declaration of interests

Nil.

7. Mohammed Fessal

Director of Pharmacy, Change Grow Live (CGL)

Declaration of interests

  • Research grants for studies relating to opioid addiction from Indivior and Ethypharm
  • Non-executive Director, West Midlands Ambulance Service (WMAS)

8.  Professor Amira Guirguis

Chief Scientist of the Royal Pharmaceutical Society (RPS), Professor of Pharmacy and MPharm Programme Director at Swansea University.

Declaration of interests

  • Financial interest: Chief Scientist of the Royal Pharmaceutical Society
  • Professor of Pharmacy, MPharm Programme Director, Pharmacist Independent Prescriber (Drug and Alcohol Services)
  • Member of the General Pharmaceutical Council’s Fitness to Practise Committee
  • Member of the Accreditation Panel of the Pharmaceutical Society of Ireland
  • In the past, has received honoraria from Jazz Pharmaceuticals and was invited to sponsored conferences by Indivior and Camurus
  • Non-financial interest: committee member of the Joint Pharmaceutical Analysis Group
  • Consultancies: expert witness (Trading Standards, Kingsman Solicitors, AH Solicitors, MB Law Ltd Solicitors)

9.  Dr Hilary Hamnett

Associate Professor in Forensic Science, University of Lincoln and Forensic Toxicologist

Declaration of interests

Nil

10. Jason Harwin

Director and Co-founder of E-T-E Solutions Limited

Declaration of interests

  • Director and co-founder of E-T-E Solutions Ltd, providing consultancy services to the private, public and voluntary sectors
  • Advisor to the Durham and Darlington Police and Crime Commissioner and co-chair of the Association of Police and Crime Commissioners Substance Misuse portfolio
  • Consultant to Social Justice Charity Cranstoun
  • Consultant services to pharmaceutical company Camurus
  • Guest presenter on PolicingTV
  • Trustee of Charity Stamp out Spiking

11. Professor Graeme Henderson

Professor of Pharmacology, University of Bristol

Declaration of interests

  • Deputy Chair of the Board of Trustees, the Bristol Drugs Project
  • Volunteer, Health and Harm Reduction Centre, Bristol Drugs Project
  • Research funding received from:
    • Medical Research Council (UK)
    • National Institute on Drug Addiction (USA)

12. Professor Katy Holloway

Professor of Criminology, University of South Wales

Declaration of interests

  • Financial interests - current research funding awarded by:

    • Innovate UK
    • Welsh Government
    • Health Care Research Wales
    • University of South Wales (Knowledge Exchange Innovation Fund)

  • Non-financial interests:

  • Advisory Group/Board membership:

    • Wales Probation Service Substance Use Officers Project
    • Ripping up the Rulebook (a Wellcome Trust funded project led by Dr Fay Dennis at Goldsmiths University of London)
    • Kaleidoscope’s Research, Development and Innovation Sub-group
    • Dyfodol, IRIS, Gwent, Dyfed Drug and Alcohol Services (DIGDAS) Executive Board
    • Public Health Wales’ Ask Check Treat (ACT) Selfcare Wound Pack project evaluation
    • Staying Safe Programme educational course for UK university students

  • Other Board membership:

    • Welsh Government’s National Implementation Board for Drug Poisoning Prevention
    • University of South Wales Wellbeing Governance Steering Group Sub-Group on Substance Use
    • Western Bay Drugs Commission
    • Welsh Centre for Alcohol and Other Drugs – Policy, Practice and Research

  • Member of the British Society for Criminology

13. Professor Keith Humphreys

Esther Ting Memorial Professor of Psychiatry, Stanford University

Declaration of interests

  • Ambassador, UK Addiction Family Support
  • Deputy Editor-in-Chief, Addiction (journal owned by the UK Society for the Study of Addiction)
  • Grantee, U.S. National Institute on Drug Abuse
  • Grantee, U.S. National Institute on Alcohol Abuse and Alcoholism
  • Non-Executive Director and shareholder, Indivior, PLC
  • Professor of Psychiatry, Stanford University
  • Senior Career Research Scientist, U.S. Veterans Health Administration
  • Scientific Advisory Board Member, Ocellaris Inc.
  • Scientific Advisory Board Member, Foundation for Opioid Response Efforts

14. Professor Stephen Husbands

Professor of Medicinal Chemistry, University of Bath

Declaration of interests

  • Funding received from US National Institutes for Health (NIDA and NIAAA), UK Research Councils and a PhD studentship from Camurus

15. Professor Sunjeev Kamboj

Professor of Translational Clinical Psychology, University College London

Declaration of interests

Nil

16. Professor Roger Knaggs

Professor of Pain Management in Clinical Pharmacy Practice, University of Nottingham. Specialist Pharmacist in Pain Management, Primary Integrated Community Services

Declaration of interests

  • President, British Pain Society.
  • Co-opted member, Faculty of Pain Medicine Board

17. Sapna Lewis

Senior Lawyer, Welsh Government Legal Services Department

Declaration of interests

Nil

18. Lorna Nisbet

Senior Lecturer and Principal Investigator for Forensic Toxicology at the Leverhulme Research Centre for Forensic Science, University of Dundee.

Declaration of interests

  • Co-Director National Drug Testing and Research Laboratory
  • Board member of the European Workplace Drug Testing Society
  • Committee Member of the LTG (formally London Toxicology Group)
  • Member of the United Kingdom and Ireland Association of Forensic Toxicologists
  • Member of the Society of Forensic Toxicologists
  • Member of the Toxicology and Pathology Investigation Network
  • Funding obtained from:
    • Scottish Government
    • Leverhulme Trust
    • Royal Society of Chemistry

19. Jon Privett

Detective Sergeant, Metropolitan Police

Declaration of interests

Nil

20. Fiona Spargo-Mabbs OBE

Director and Founder, Daniel Sargo-Mabbs Foundation. Chair, Drug Education Forum.

Declaration of interests

  • Director and Founder of drug education charity the Daniel Sargo-Mabbs Foundation 2016 - present
  • Chair of the Daniel Spargo-Mabbs Foundation 2014-2016
  • Chair of Drug Education Forum 2024 to present
  • Chair of Drugs on Social Media working group 2021-2024
  • Lead applicant on Phase 1 NIHR Innovation Fund to Reduce the Demand for Illicit Substances 2023
  • Joint lead applicant on Phase 2 NIHR Innovation Fund to Reduce the Demand for Illicit Substances 2024-25
  • Co-applicant on Phase 3 NIHR Innovation Fund to Reduce the Demand for Illicit Sub-stances 2026-27
  • Former member Home Office Reducing Demand programme board 2022 - 2024.
  • Husband and son are Trustees of the Daniel Spargo-Mabbs Foundation.
  • Research funding received from NIHR

21. Professor Harry Sumnall

Professor in Substance Use, Liverpool John Moores University (LJMU)

Declaration of interests

  • Receives funding from UK and international research councils and charities.
  • Scientific Advisor:
    • MIND Foundation, Germany
    • International Society of Substance Use Professionals (ISSUP)
    • UK Drug Education Forum
  • Scientific Board – Lisbon Addictions conference
  • Steering Committee Member: Anti Stigma Network
  • Former Board Member/Past President of the European Society for Prevention Research (EUSPR)
  • Editorial Board member Journal of Prevention, Addictive Behaviour
  • Consultancies and honoraria from international agencies, Ministries, founders, charities, drug treatment service providers, and pharmaceutical and biotech industries (peer review, training, education, and consultancy)

22. Professor Simon Thomas

Emeritus Professor, Clinical Pharmacology and Therapeutics, Newcastle University

Declaration of interests

  • Member, Ministry of Defence Advisory Group on Military and Emergency Response Medicine
  • Research funding received from:
    • DHSC - OHID
    • National Institute for Health Research
    • Ministry of Defence

23. Dr David Wood

Professor of Clinical Toxicology and Consultant Physician, Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners and King’s College London.

Declaration of interests

  • Clinical co-ordinator, National Confidential Enquiry on Patient Outcome and Death
  • Trustee, Positive East
  • Senior Editor, Journal of Medical Toxicology
  • International Editorial Board, British Journal of Clinical Pharmacology
  • Expert advisor to:
    • European Union Drugs Agency (previously known as the European Monitoring Centre for Drugs and Drug Addiction)
    • United Nations Office on Drugs and Crime
    • World Health Organisation
  • Funding/Grants received from:
    • European Union
    • European Union Drugs Agency (formerly known as the European Monitoring Centre for Drugs and Drug Addiction)
    • National Institute for Health Research
    • Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system
    • United Nations Office on Drugs and Crime
Back to top